LHPP-P38 MAPK/ERK-ETS1轴负反信号抑制乳腺癌的进展
1Abdominal Radiotherapy Department, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang Province, China.
Cancer science
|January 10, 2025
概括
低水平的LHPP蛋白与乳腺癌 (BRCA) 的不良结果有关. 这项研究揭示了LHPP通过调节MAPK信号通路来抑制BRCA细胞入侵和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 侵袭和转移是乳腺癌 (BRCA) 患者死亡率的主要驱动因素.
- 已知瘤抑制剂LHPP在BRCA进展中的作用仍然不清楚.
研究的目的:
- 研究LHPP在乳腺癌中的作用.
- 阐明LHPP影响BRCA入侵和转移的潜在分子机制.
主要方法:
- 对BRCA组织中LHPP蛋白水平的分析和与患者结果的相关性.
- 在体外测试以评估LHPP对BRCA细胞增殖,迁移,入侵和干细胞的影响.
- 在体内异种移植模型评估LHPP对瘤发生和转移的影响.
- 涉及蛋白质与蛋白质相互作用和途径分析的机制研究 (MAPK,ERK,P38,MAPK,ETS1).
主要成果:
- 在BRCA组织中观察到LHPP蛋白表达的减少,与较差的患者结果相关.
- 在体外,LHPP显著抑制了BRCA细胞的增殖,迁移,入侵和干细胞.
- 在体内,LHPP抑制了瘤生长和肺转移.
- LHPP与ERK和P38 MAPK相互作用,导致途径抑制.
- ETS1被确定为LHPPmRNA转录的抑制剂,形成负反循环.
结论:
- 在乳腺癌中,LHPP充当瘤抑制剂,抑制入侵和转移的关键过程.
- 一个新的LHPP-MAPK-ETS1负反循环调节BRCA入侵和转移.
- 乳腺癌转移 LHPP 是减少乳腺癌转移的潜在治疗标.
相关概念视频
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:07MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K